|
gptkbp:instanceOf
|
gptkb:drug
monoamine oxidase inhibitor
|
|
gptkbp:approvedBy
|
1959
|
|
gptkbp:ATCCode
|
N06AF02
|
|
gptkbp:CASNumber
|
59-63-2
|
|
gptkbp:contraindication
|
gptkb:liver_disease
gptkb:pheochromocytoma
severe renal impairment
|
|
gptkbp:discoveredBy
|
gptkb:Hoffmann-La_Roche
|
|
gptkbp:drugInteraction
|
gptkb:tricyclic_antidepressants
gptkb:SSRIs
gptkb:sympathomimetics
|
|
gptkbp:eliminationHalfLife
|
1.5-4 hours
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:hasMolecularFormula
|
C12H13N3O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
isocarboxazid
|
|
gptkbp:IUPACName
|
gptkb:N'-benzyl-5-methylisoxazole-3-carbohydrazide
|
|
gptkbp:KEGGID
|
D00338
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:MeSH_ID
|
D007566
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
3630
3760
CHEMBL1201
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
weight gain
insomnia
dry mouth
hypertensive crisis
|
|
gptkbp:synonym
|
gptkb:Marplan
|
|
gptkbp:UNII
|
Q60VQ85798
|
|
gptkbp:usedFor
|
gptkb:depression
|
|
gptkbp:bfsParent
|
gptkb:monoamine_oxidase_inhibitors
gptkb:MAO_inhibitors
|
|
gptkbp:bfsLayer
|
6
|